Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonography | 76 | 2022 | 350 | 16.860 |
Why?
|
Carpal Tunnel Syndrome | 20 | 2022 | 61 | 7.480 |
Why?
|
Peripheral Nerves | 14 | 2022 | 59 | 6.130 |
Why?
|
Muscle, Skeletal | 19 | 2020 | 496 | 4.850 |
Why?
|
Neural Conduction | 24 | 2021 | 82 | 4.160 |
Why?
|
Median Nerve | 15 | 2022 | 45 | 4.060 |
Why?
|
Amyotrophic Lateral Sclerosis | 11 | 2020 | 62 | 4.030 |
Why?
|
Ulnar Neuropathies | 5 | 2021 | 17 | 2.890 |
Why?
|
Neuromuscular Junction | 6 | 2022 | 67 | 2.850 |
Why?
|
Ulnar Nerve | 10 | 2022 | 23 | 2.770 |
Why?
|
Peripheral Nervous System Diseases | 6 | 2022 | 46 | 2.700 |
Why?
|
Humans | 111 | 2022 | 29552 | 2.650 |
Why?
|
Electrodiagnosis | 11 | 2022 | 36 | 2.620 |
Why?
|
Neuromuscular Diseases | 7 | 2021 | 14 | 2.270 |
Why?
|
Male | 67 | 2022 | 18012 | 2.020 |
Why?
|
Occupational Diseases | 6 | 2016 | 83 | 1.980 |
Why?
|
Polyneuropathies | 5 | 2019 | 10 | 1.890 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 3 | 2021 | 6 | 1.870 |
Why?
|
Adult | 46 | 2022 | 8528 | 1.740 |
Why?
|
Muscular Atrophy, Spinal | 3 | 2022 | 4 | 1.730 |
Why?
|
Female | 60 | 2022 | 18379 | 1.680 |
Why?
|
Middle Aged | 47 | 2020 | 10936 | 1.650 |
Why?
|
Diaphragm | 7 | 2018 | 46 | 1.610 |
Why?
|
Oligonucleotides | 3 | 2022 | 28 | 1.550 |
Why?
|
Myositis, Inclusion Body | 3 | 2019 | 7 | 1.410 |
Why?
|
Aged | 33 | 2020 | 9590 | 1.150 |
Why?
|
Charcot-Marie-Tooth Disease | 2 | 2020 | 6 | 1.070 |
Why?
|
Brachial Plexus | 2 | 2018 | 26 | 1.060 |
Why?
|
Radial Nerve | 4 | 2022 | 17 | 1.060 |
Why?
|
Sural Nerve | 4 | 2020 | 23 | 1.050 |
Why?
|
Cubital Tunnel Syndrome | 4 | 2008 | 10 | 1.020 |
Why?
|
Azo Compounds | 2 | 2021 | 3 | 1.000 |
Why?
|
Nerve Compression Syndromes | 3 | 2013 | 8 | 0.980 |
Why?
|
Recombinant Fusion Proteins | 2 | 2021 | 97 | 0.960 |
Why?
|
Elbow | 6 | 2021 | 25 | 0.960 |
Why?
|
Hispanic Americans | 7 | 2016 | 903 | 0.950 |
Why?
|
Young Adult | 13 | 2020 | 2431 | 0.950 |
Why?
|
Pyrimidines | 2 | 2021 | 60 | 0.950 |
Why?
|
Neuromuscular Agents | 2 | 2021 | 28 | 0.920 |
Why?
|
Biological Products | 2 | 2021 | 66 | 0.910 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 2022 | 2 | 0.880 |
Why?
|
Brachial Plexus Neuritis | 1 | 2022 | 1 | 0.870 |
Why?
|
Electromyography | 8 | 2019 | 58 | 0.860 |
Why?
|
Elbow Joint | 2 | 2021 | 53 | 0.860 |
Why?
|
Motor Neuron Disease | 2 | 2019 | 4 | 0.850 |
Why?
|
Wrist | 4 | 2020 | 41 | 0.850 |
Why?
|
Forearm | 4 | 2020 | 37 | 0.820 |
Why?
|
Reproducibility of Results | 9 | 2019 | 727 | 0.810 |
Why?
|
Stroke | 6 | 2013 | 552 | 0.800 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2021 | 3 | 0.800 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2021 | 9 | 0.790 |
Why?
|
Myasthenia Gravis | 2 | 2016 | 12 | 0.790 |
Why?
|
Observer Variation | 3 | 2019 | 96 | 0.790 |
Why?
|
Oligonucleotides, Antisense | 1 | 2021 | 30 | 0.780 |
Why?
|
Education, Medical, Undergraduate | 2 | 2017 | 86 | 0.770 |
Why?
|
Myotonic Disorders | 1 | 2020 | 3 | 0.740 |
Why?
|
Radial Neuropathy | 2 | 2011 | 11 | 0.740 |
Why?
|
Child | 8 | 2022 | 2233 | 0.730 |
Why?
|
Hand | 1 | 2020 | 63 | 0.710 |
Why?
|
Curriculum | 3 | 2019 | 198 | 0.710 |
Why?
|
Sensory Receptor Cells | 1 | 2020 | 29 | 0.710 |
Why?
|
Motor Neurons | 1 | 2020 | 53 | 0.710 |
Why?
|
Diagnostic Techniques, Neurological | 2 | 2019 | 6 | 0.700 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 94 | 0.680 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2019 | 1 | 0.680 |
Why?
|
Vagus Nerve | 2 | 2017 | 29 | 0.660 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 1225 | 0.660 |
Why?
|
Nerve Tissue | 1 | 2018 | 2 | 0.660 |
Why?
|
Body Height | 1 | 2018 | 31 | 0.660 |
Why?
|
Tracheostomy | 1 | 2019 | 28 | 0.660 |
Why?
|
Musculoskeletal Diseases | 2 | 2016 | 36 | 0.650 |
Why?
|
Fasciitis | 1 | 2018 | 2 | 0.640 |
Why?
|
Body Weight | 2 | 2018 | 290 | 0.640 |
Why?
|
Respiration, Artificial | 1 | 2019 | 96 | 0.640 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2018 | 7 | 0.640 |
Why?
|
Pilot Projects | 7 | 2020 | 489 | 0.640 |
Why?
|
Eosinophilia | 1 | 2018 | 16 | 0.630 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2018 | 36 | 0.620 |
Why?
|
Reference Values | 5 | 2022 | 225 | 0.610 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 168 | 0.600 |
Why?
|
Upper Extremity | 1 | 2017 | 53 | 0.590 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2017 | 4 | 0.590 |
Why?
|
Elasticity Imaging Techniques | 1 | 2017 | 9 | 0.590 |
Why?
|
Food-Processing Industry | 3 | 2014 | 41 | 0.580 |
Why?
|
Nutritional Sciences | 1 | 2017 | 8 | 0.580 |
Why?
|
Peroneal Nerve | 2 | 2013 | 15 | 0.580 |
Why?
|
Scapula | 1 | 2017 | 18 | 0.580 |
Why?
|
Adolescent | 9 | 2020 | 3284 | 0.570 |
Why?
|
Aged, 80 and over | 12 | 2018 | 3764 | 0.570 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 18 | 0.550 |
Why?
|
Receptors, Cholinergic | 1 | 2016 | 22 | 0.540 |
Why?
|
Diabetic Neuropathies | 2 | 2017 | 23 | 0.540 |
Why?
|
Muscle Cramp | 1 | 2015 | 3 | 0.530 |
Why?
|
Case-Control Studies | 7 | 2019 | 861 | 0.530 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2015 | 3 | 0.530 |
Why?
|
Facial Muscles | 1 | 2015 | 1 | 0.530 |
Why?
|
Bell Palsy | 1 | 2015 | 1 | 0.530 |
Why?
|
Clinical Competence | 3 | 2022 | 310 | 0.530 |
Why?
|
Biomedical Research | 1 | 2017 | 156 | 0.530 |
Why?
|
Facial Nerve | 1 | 2015 | 3 | 0.520 |
Why?
|
Lymphoma | 1 | 2015 | 36 | 0.510 |
Why?
|
Sports | 1 | 2015 | 33 | 0.500 |
Why?
|
Prospective Studies | 7 | 2021 | 2046 | 0.500 |
Why?
|
Retrospective Studies | 8 | 2022 | 3144 | 0.490 |
Why?
|
Brain Concussion | 1 | 2015 | 61 | 0.490 |
Why?
|
Meningitis | 1 | 2014 | 9 | 0.490 |
Why?
|
Carpal Bones | 1 | 2014 | 13 | 0.490 |
Why?
|
Ganglion Cysts | 1 | 2013 | 6 | 0.470 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2013 | 5 | 0.450 |
Why?
|
Peripheral Nervous System | 2 | 2014 | 6 | 0.450 |
Why?
|
Sciatic Nerve | 1 | 2013 | 35 | 0.440 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 81 | 0.440 |
Why?
|
Nervous System | 1 | 2013 | 15 | 0.440 |
Why?
|
Disease Management | 1 | 2013 | 114 | 0.430 |
Why?
|
Severity of Illness Index | 2 | 2013 | 864 | 0.420 |
Why?
|
Age Factors | 2 | 2013 | 1120 | 0.420 |
Why?
|
Treatment Outcome | 5 | 2021 | 3128 | 0.410 |
Why?
|
Poultry Products | 1 | 2012 | 13 | 0.410 |
Why?
|
Emigrants and Immigrants | 3 | 2016 | 234 | 0.410 |
Why?
|
Joint Instability | 1 | 2013 | 72 | 0.410 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 61 | 0.400 |
Why?
|
African Americans | 1 | 2019 | 1375 | 0.400 |
Why?
|
Mononeuropathies | 1 | 2011 | 2 | 0.400 |
Why?
|
Posture | 2 | 2015 | 53 | 0.390 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2009 | 21 | 0.390 |
Why?
|
Myography | 3 | 2018 | 6 | 0.390 |
Why?
|
Infant | 3 | 2021 | 976 | 0.390 |
Why?
|
Electric Impedance | 3 | 2018 | 13 | 0.390 |
Why?
|
Steroids | 1 | 2011 | 36 | 0.390 |
Why?
|
Mass Screening | 1 | 2013 | 227 | 0.390 |
Why?
|
Median Neuropathy | 2 | 2013 | 6 | 0.380 |
Why?
|
Cross-Sectional Studies | 5 | 2020 | 1389 | 0.380 |
Why?
|
Arm Injuries | 1 | 2011 | 20 | 0.380 |
Why?
|
Wounds, Gunshot | 1 | 2011 | 34 | 0.370 |
Why?
|
Arnold-Chiari Malformation | 1 | 2010 | 8 | 0.370 |
Why?
|
Brachial Artery | 2 | 2013 | 66 | 0.370 |
Why?
|
Deglutition Disorders | 1 | 2010 | 50 | 0.360 |
Why?
|
Sensitivity and Specificity | 6 | 2019 | 533 | 0.350 |
Why?
|
Cranial Nerves | 1 | 2009 | 7 | 0.350 |
Why?
|
Incontinentia Pigmenti | 1 | 2009 | 1 | 0.340 |
Why?
|
Thromboembolism | 1 | 2009 | 30 | 0.330 |
Why?
|
Edema | 1 | 2008 | 30 | 0.330 |
Why?
|
Practice Guidelines as Topic | 2 | 2022 | 376 | 0.320 |
Why?
|
Ultrasonography, Interventional | 1 | 2008 | 51 | 0.310 |
Why?
|
Anatomy, Cross-Sectional | 5 | 2013 | 14 | 0.300 |
Why?
|
Muscle Contraction | 2 | 2020 | 114 | 0.300 |
Why?
|
Students, Medical | 2 | 2020 | 121 | 0.290 |
Why?
|
Tibial Nerve | 2 | 2020 | 17 | 0.290 |
Why?
|
Joints | 1 | 2006 | 9 | 0.280 |
Why?
|
Arteries | 1 | 2006 | 61 | 0.280 |
Why?
|
Aneurysm, False | 1 | 2005 | 13 | 0.260 |
Why?
|
Telencephalon | 1 | 2005 | 3 | 0.260 |
Why?
|
Nervous System Malformations | 1 | 2005 | 9 | 0.260 |
Why?
|
Tuberous Sclerosis | 1 | 2005 | 7 | 0.260 |
Why?
|
Quadriceps Muscle | 2 | 2015 | 31 | 0.260 |
Why?
|
Epinephrine | 1 | 2005 | 41 | 0.260 |
Why?
|
Spinal Puncture | 1 | 2005 | 20 | 0.260 |
Why?
|
Medical Staff, Hospital | 1 | 2005 | 18 | 0.260 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2005 | 41 | 0.260 |
Why?
|
Abnormalities, Multiple | 1 | 2005 | 24 | 0.260 |
Why?
|
Myocardial Infarction | 1 | 2009 | 424 | 0.250 |
Why?
|
Dysarthria | 1 | 2004 | 3 | 0.250 |
Why?
|
Prevalence | 5 | 2016 | 910 | 0.250 |
Why?
|
Cerebral Hemorrhage | 1 | 2005 | 62 | 0.250 |
Why?
|
Intensive Care Units | 3 | 2015 | 120 | 0.250 |
Why?
|
Heptanoic Acids | 1 | 2004 | 28 | 0.250 |
Why?
|
Respiratory Paralysis | 2 | 2015 | 5 | 0.240 |
Why?
|
Wounds and Injuries | 1 | 2007 | 251 | 0.240 |
Why?
|
Pyrroles | 1 | 2004 | 55 | 0.240 |
Why?
|
Back Pain | 2 | 2014 | 28 | 0.240 |
Why?
|
Postural Balance | 1 | 2016 | 163 | 0.240 |
Why?
|
United States | 4 | 2020 | 3692 | 0.230 |
Why?
|
Pesticides | 1 | 2016 | 188 | 0.230 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 493 | 0.230 |
Why?
|
Child, Preschool | 2 | 2020 | 1172 | 0.230 |
Why?
|
Occupational Exposure | 1 | 2016 | 223 | 0.220 |
Why?
|
Hypertrophy | 1 | 2022 | 26 | 0.220 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 137 | 0.220 |
Why?
|
Logistic Models | 2 | 2016 | 729 | 0.220 |
Why?
|
Transients and Migrants | 1 | 2016 | 280 | 0.220 |
Why?
|
Shoulder Pain | 1 | 2022 | 10 | 0.210 |
Why?
|
Organ Size | 2 | 2013 | 196 | 0.210 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 44 | 0.210 |
Why?
|
Neurologic Examination | 3 | 2017 | 28 | 0.210 |
Why?
|
Muscle Weakness | 3 | 2017 | 39 | 0.210 |
Why?
|
Time Factors | 4 | 2019 | 2014 | 0.210 |
Why?
|
Vital Capacity | 2 | 2018 | 44 | 0.210 |
Why?
|
Learning | 1 | 2022 | 76 | 0.210 |
Why?
|
Consensus | 1 | 2022 | 70 | 0.200 |
Why?
|
North Carolina | 5 | 2016 | 1430 | 0.200 |
Why?
|
Education, Distance | 1 | 2021 | 13 | 0.200 |
Why?
|
Follow-Up Studies | 2 | 2018 | 2124 | 0.200 |
Why?
|
Evoked Potentials, Motor | 2 | 2018 | 8 | 0.190 |
Why?
|
Membrane Proteins | 1 | 2022 | 257 | 0.190 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 275 | 0.190 |
Why?
|
Mutation | 1 | 2022 | 475 | 0.180 |
Why?
|
Fluoroscopy | 1 | 2020 | 39 | 0.180 |
Why?
|
Neurology | 1 | 2020 | 45 | 0.180 |
Why?
|
Cadaver | 2 | 2013 | 145 | 0.180 |
Why?
|
Movement Disorders | 2 | 2010 | 25 | 0.180 |
Why?
|
Injections, Spinal | 1 | 2020 | 124 | 0.180 |
Why?
|
Demyelinating Diseases | 1 | 2019 | 7 | 0.180 |
Why?
|
Taxoids | 1 | 2020 | 48 | 0.180 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 525 | 0.180 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 23 | 0.170 |
Why?
|
Guidelines as Topic | 1 | 2019 | 46 | 0.170 |
Why?
|
Anisotropy | 1 | 2019 | 10 | 0.170 |
Why?
|
Myotonic Dystrophy | 1 | 2018 | 4 | 0.170 |
Why?
|
Survival Rate | 2 | 2019 | 797 | 0.160 |
Why?
|
Sample Size | 1 | 2018 | 37 | 0.160 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 161 | 0.160 |
Why?
|
Immunosuppression | 1 | 2018 | 80 | 0.160 |
Why?
|
Muscular Diseases | 2 | 2011 | 19 | 0.160 |
Why?
|
Leukocyte Count | 1 | 2018 | 55 | 0.160 |
Why?
|
Prednisone | 1 | 2018 | 43 | 0.160 |
Why?
|
Eosinophils | 1 | 2018 | 48 | 0.160 |
Why?
|
Critical Illness | 2 | 2015 | 88 | 0.150 |
Why?
|
Cohort Studies | 2 | 2018 | 1701 | 0.150 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 299 | 0.150 |
Why?
|
Equipment Design | 1 | 2018 | 167 | 0.150 |
Why?
|
Animals | 4 | 2021 | 7339 | 0.150 |
Why?
|
Vaccination | 1 | 2018 | 126 | 0.150 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 91 | 0.150 |
Why?
|
Feasibility Studies | 1 | 2018 | 270 | 0.150 |
Why?
|
Incidence | 2 | 2013 | 1127 | 0.150 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 796 | 0.140 |
Why?
|
Nervous System Diseases | 1 | 2017 | 37 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 471 | 0.140 |
Why?
|
Health Status | 1 | 2018 | 373 | 0.140 |
Why?
|
Longitudinal Studies | 2 | 2015 | 727 | 0.140 |
Why?
|
Patient Compliance | 1 | 2018 | 213 | 0.140 |
Why?
|
Community Health Planning | 1 | 2016 | 9 | 0.140 |
Why?
|
Atrophy | 1 | 2016 | 52 | 0.140 |
Why?
|
Action Potentials | 1 | 2016 | 175 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2017 | 180 | 0.130 |
Why?
|
Wasting Syndrome | 1 | 2015 | 14 | 0.130 |
Why?
|
Hyoid Bone | 1 | 2015 | 5 | 0.130 |
Why?
|
Respiratory Distress Syndrome, Adult | 1 | 2015 | 55 | 0.130 |
Why?
|
Disulfiram | 1 | 2014 | 1 | 0.130 |
Why?
|
Alcohol Deterrents | 1 | 2014 | 2 | 0.130 |
Why?
|
Laryngeal Muscles | 1 | 2015 | 16 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 548 | 0.130 |
Why?
|
Injections, Intramuscular | 1 | 2015 | 42 | 0.130 |
Why?
|
Infant, Newborn | 2 | 2009 | 605 | 0.130 |
Why?
|
Neurotoxicity Syndromes | 1 | 2014 | 17 | 0.130 |
Why?
|
Deglutition | 1 | 2015 | 29 | 0.130 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 5 | 0.120 |
Why?
|
Ideal Body Weight | 1 | 2014 | 7 | 0.120 |
Why?
|
European Continental Ancestry Group | 1 | 2019 | 1132 | 0.120 |
Why?
|
Muscle Strength | 1 | 2015 | 145 | 0.120 |
Why?
|
Workplace | 1 | 2014 | 47 | 0.120 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 113 | 0.120 |
Why?
|
Child Care | 1 | 2014 | 10 | 0.120 |
Why?
|
Industry | 1 | 2014 | 15 | 0.120 |
Why?
|
Tennis Elbow | 1 | 2014 | 18 | 0.120 |
Why?
|
Lower Extremity | 1 | 2014 | 97 | 0.120 |
Why?
|
Alcoholism | 1 | 2014 | 99 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2020 | 680 | 0.120 |
Why?
|
Intercostal Muscles | 1 | 2013 | 2 | 0.110 |
Why?
|
Respiratory Muscles | 1 | 2013 | 7 | 0.110 |
Why?
|
Athletes | 1 | 2013 | 65 | 0.110 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 111 | 0.110 |
Why?
|
Comorbidity | 2 | 2011 | 548 | 0.110 |
Why?
|
Body Mass Index | 1 | 2016 | 876 | 0.110 |
Why?
|
Echocardiography | 1 | 2013 | 141 | 0.110 |
Why?
|
Life Style | 1 | 2013 | 369 | 0.100 |
Why?
|
Depression | 1 | 2014 | 386 | 0.100 |
Why?
|
Wrist Joint | 1 | 2011 | 53 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2011 | 67 | 0.100 |
Why?
|
History, 21st Century | 1 | 2011 | 49 | 0.100 |
Why?
|
History, 20th Century | 1 | 2011 | 69 | 0.100 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 209 | 0.100 |
Why?
|
Neurophysiology | 1 | 2010 | 9 | 0.090 |
Why?
|
Pseudobulbar Palsy | 1 | 2010 | 5 | 0.090 |
Why?
|
Gastroesophageal Reflux | 1 | 2010 | 25 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 2 | 2005 | 874 | 0.090 |
Why?
|
Endoscopy | 1 | 2010 | 40 | 0.090 |
Why?
|
Mood Disorders | 1 | 2010 | 19 | 0.090 |
Why?
|
Risk Factors | 2 | 2009 | 3600 | 0.090 |
Why?
|
Vasculitis | 1 | 2009 | 23 | 0.090 |
Why?
|
Glomerulonephritis | 1 | 2009 | 21 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2011 | 95 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2010 | 49 | 0.090 |
Why?
|
Myelin P0 Protein | 1 | 2009 | 4 | 0.090 |
Why?
|
Family Health | 1 | 2009 | 78 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2009 | 141 | 0.080 |
Why?
|
Causality | 1 | 2008 | 39 | 0.080 |
Why?
|
Disease Progression | 3 | 2018 | 574 | 0.080 |
Why?
|
Aspirin | 1 | 2009 | 66 | 0.080 |
Why?
|
Physicians | 1 | 2010 | 136 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 1389 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2009 | 85 | 0.080 |
Why?
|
Recurrence | 1 | 2009 | 235 | 0.080 |
Why?
|
Odds Ratio | 1 | 2009 | 448 | 0.080 |
Why?
|
Denervation | 1 | 2007 | 13 | 0.070 |
Why?
|
Electric Stimulation | 1 | 2007 | 102 | 0.070 |
Why?
|
Reaction Time | 1 | 2007 | 121 | 0.070 |
Why?
|
Weight Loss | 1 | 2010 | 416 | 0.070 |
Why?
|
Asthma | 1 | 2010 | 397 | 0.070 |
Why?
|
Muscle Strength Dynamometer | 2 | 2018 | 11 | 0.070 |
Why?
|
Torsion Abnormality | 1 | 2006 | 7 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2006 | 107 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2007 | 167 | 0.070 |
Why?
|
Tissue Adhesions | 1 | 2005 | 9 | 0.070 |
Why?
|
Paresthesia | 1 | 2005 | 9 | 0.070 |
Why?
|
Angiomyolipoma | 1 | 2005 | 6 | 0.070 |
Why?
|
Infusions, Intravenous | 1 | 2005 | 85 | 0.070 |
Why?
|
Rhabdomyoma | 1 | 2005 | 3 | 0.070 |
Why?
|
Hyperplasia | 1 | 2005 | 38 | 0.060 |
Why?
|
Catheterization | 1 | 2005 | 58 | 0.060 |
Why?
|
Choristoma | 1 | 2005 | 17 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 2005 | 14 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2005 | 92 | 0.060 |
Why?
|
Ossification, Heterotopic | 1 | 2005 | 14 | 0.060 |
Why?
|
Pyridostigmine Bromide | 1 | 2004 | 1 | 0.060 |
Why?
|
Lovastatin | 1 | 2004 | 6 | 0.060 |
Why?
|
Thalamus | 1 | 2005 | 39 | 0.060 |
Why?
|
Ubiquinone | 1 | 2004 | 8 | 0.060 |
Why?
|
Th2 Cells | 1 | 2004 | 14 | 0.060 |
Why?
|
Pravastatin | 1 | 2004 | 12 | 0.060 |
Why?
|
Decompression, Surgical | 1 | 2005 | 53 | 0.060 |
Why?
|
Skull | 1 | 2005 | 45 | 0.060 |
Why?
|
Simvastatin | 1 | 2004 | 25 | 0.060 |
Why?
|
Dogs | 2 | 2015 | 117 | 0.060 |
Why?
|
Quality of Life | 1 | 2010 | 833 | 0.060 |
Why?
|
Hyperlipidemias | 1 | 2004 | 52 | 0.060 |
Why?
|
Models, Neurological | 1 | 2004 | 115 | 0.060 |
Why?
|
Cytokines | 1 | 2004 | 243 | 0.060 |
Why?
|
Mitochondria | 1 | 2004 | 181 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 192 | 0.050 |
Why?
|
Prognosis | 1 | 2006 | 1372 | 0.050 |
Why?
|
Educational Status | 1 | 2022 | 165 | 0.050 |
Why?
|
Technology | 1 | 2021 | 8 | 0.050 |
Why?
|
Brain | 1 | 2009 | 933 | 0.050 |
Why?
|
Obesity | 1 | 2008 | 1081 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 1058 | 0.050 |
Why?
|
Professional Practice | 1 | 2020 | 23 | 0.050 |
Why?
|
Career Choice | 1 | 2020 | 40 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2005 | 676 | 0.050 |
Why?
|
Research | 1 | 2020 | 72 | 0.050 |
Why?
|
Ankle | 1 | 2020 | 23 | 0.040 |
Why?
|
Epidermis | 1 | 2020 | 25 | 0.040 |
Why?
|
Albumins | 1 | 2020 | 39 | 0.040 |
Why?
|
Nerve Fibers | 1 | 2020 | 31 | 0.040 |
Why?
|
Paclitaxel | 1 | 2020 | 51 | 0.040 |
Why?
|
Leg | 1 | 2020 | 57 | 0.040 |
Why?
|
Delphi Technique | 1 | 2019 | 35 | 0.040 |
Why?
|
Genetic Testing | 1 | 2018 | 90 | 0.040 |
Why?
|
Hypertension | 1 | 2004 | 918 | 0.040 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 14 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 283 | 0.040 |
Why?
|
Head | 1 | 2017 | 47 | 0.040 |
Why?
|
Critical Care | 1 | 2015 | 115 | 0.030 |
Why?
|
Patient Discharge | 1 | 2015 | 171 | 0.030 |
Why?
|
Food Industry | 1 | 2013 | 8 | 0.030 |
Why?
|
Recovery of Function | 1 | 2014 | 190 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2015 | 389 | 0.030 |
Why?
|
Leprosy, Lepromatous | 1 | 2011 | 1 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 984 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 45 | 0.020 |
Why?
|
Emaciation | 1 | 2010 | 4 | 0.020 |
Why?
|
Adiposity | 1 | 2011 | 192 | 0.020 |
Why?
|
Essential Tremor | 1 | 2010 | 13 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2010 | 74 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2010 | 71 | 0.020 |
Why?
|
Health Surveys | 1 | 2010 | 192 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2010 | 68 | 0.020 |
Why?
|
Weight Gain | 1 | 2010 | 109 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 381 | 0.020 |
Why?
|